NEW YORK, April 15, 2004 (PRIMEZONE) -- Amazon Biotech Inc. (OTCBB:AMZB) today announced the appointment of Dr. Angelo A. Chinnici as Company Chief Officer. Dr. Chinicci has been in clinical practice for over 20 years, and been affiliated with Meridian Healthcare and the University of Medicine and Dentistry of New Jersey for over 15 years. His affiliation with the Meridian Healthcare has given him the opportunity to be involved with a vast number of HIV infected patients and be involved with the day-to-day management of ooportunistic infections and viral-load evaluations.
About Amazon Biotech
Amazon Biotech, Corp. is a newly established pharmaceutical company currently producing AMZ 0026 and a revolutionary, topical natural hair-growth product. The company intends to initiate Phase I/II clinical studies of AMZ 0026 in the near future, with an eventual goal of a joint venture with a major pharmaceutical company in Phase III trials. During 2004, Amazon Biotech plans to conduct a double blind study on its hair growth product. The company also plans to market the hair growth product through a Fortune 1000 company. Additional information on Amazon Biotech may be found at www.amazonbiotech.com
FORWARD LOOKING STATEMENTS:
"Safe-Harbor" Statement Under the Private Securities Litigation Reform Act of 1995 This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, including statements regarding any potential sales of products as well as statements that include the words "believes," "expects," "anticipates," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance, or achievements of Amazon Biotech, to differ materially from those implied or expressed by such forward-looking statements. Such factors include, among others, the risk factors included in Amazon Biotech's subsequent reports filed with the Securities and Exchange Commission under the Exchange Act. This press release speaks as of the date first set forth above and Amazon Biotech assumes no responsibility to update the information included herein for events occurring after the date hereof.